ES2061821T3 - Utilizacion terapeutica del derivado ester isopropilo de monosialgangliosido en patologias nerviosas con componente inflamatoria. - Google Patents
Utilizacion terapeutica del derivado ester isopropilo de monosialgangliosido en patologias nerviosas con componente inflamatoria.Info
- Publication number
- ES2061821T3 ES2061821T3 ES89113160T ES89113160T ES2061821T3 ES 2061821 T3 ES2061821 T3 ES 2061821T3 ES 89113160 T ES89113160 T ES 89113160T ES 89113160 T ES89113160 T ES 89113160T ES 2061821 T3 ES2061821 T3 ES 2061821T3
- Authority
- ES
- Spain
- Prior art keywords
- monosialganglioside
- therapeutic use
- inflammatory component
- derivative
- ester isopropyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- -1 ISOPROPYL Chemical class 0.000 title 1
- 230000002757 inflammatory effect Effects 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 230000002322 anti-exudative effect Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- QPJBWNIQKHGLAU-IQZHVAEDSA-N ganglioside GM1 Chemical compound O[C@@H]1[C@@H](O)[C@H](OC[C@H](NC(=O)CCCCCCCCCCCCCCCCC)[C@H](O)\C=C\CCCCCCCCCCCCC)O[C@H](CO)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@]2(O[C@H]([C@H](NC(C)=O)[C@@H](O)C2)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)[C@@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](CO)O1 QPJBWNIQKHGLAU-IQZHVAEDSA-N 0.000 abstract 1
- 230000009897 systematic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
- C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Biochemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Genetics & Genomics (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
L DERIVADO DEL ESTER ISOPROPIL DEL GANGLIOSIDO GM1 ESTA PROBADO QUE EXHIBE ACTIVIDADES ANTIINFLAMATORIAS Y ANTIEXUDATIVAS Y POR TANTO ES UTIL EN EL TRATAMIENTO DE VARIAS PATOLOGIAS SISTEMATICAS, OFTALMICAS O TOPICAS, EN PARTICULAR DE AQUELLAS PATOLOGIAS CARACTERIZADAS EN FENOMENOS INFLAMATORIOS. EL DERIVADO ESTA TAMBIEN PROBADO QUE ES ACTIVO DESPUES DE LA ADMINISTRACION TANTO ORAL COMO TOPICA.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT8848208A IT1224513B (it) | 1988-07-19 | 1988-07-19 | Uso terapeutico del derivato estere isopropilico del monosialogangliosi de in patologie ad interessamento nervoso con componente infiammatoria |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2061821T3 true ES2061821T3 (es) | 1994-12-16 |
Family
ID=11265246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES89113160T Expired - Lifetime ES2061821T3 (es) | 1988-07-19 | 1989-07-18 | Utilizacion terapeutica del derivado ester isopropilo de monosialgangliosido en patologias nerviosas con componente inflamatoria. |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0351784B1 (es) |
| JP (1) | JPH0278622A (es) |
| AT (1) | ATE97812T1 (es) |
| AU (1) | AU624164B2 (es) |
| DE (1) | DE68911049T2 (es) |
| DK (1) | DK354589A (es) |
| ES (1) | ES2061821T3 (es) |
| IT (1) | IT1224513B (es) |
| PH (1) | PH26117A (es) |
| ZA (1) | ZA895367B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09278653A (ja) * | 1996-04-05 | 1997-10-28 | Santen Pharmaceut Co Ltd | 網膜疾患治療剤 |
| US6998392B2 (en) | 2003-04-02 | 2006-02-14 | Mti Meta Tech Inc. | Formulation to treat or prevent parasitic infection |
| US8536140B2 (en) | 2004-03-12 | 2013-09-17 | Mti Meta Tech Inc. | Methods for treating inflammatory bowel disease |
| US7851451B2 (en) | 2004-03-12 | 2010-12-14 | Mti Meta Tech Inc. | Formulations for mediating inflammatory bowel disorders |
| CN104490837A (zh) * | 2014-12-30 | 2015-04-08 | 哈尔滨医科大学科技开发总公司 | 单唾液酸四己糖神经节苷脂钠的口服制剂 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1199116B (it) * | 1984-07-03 | 1988-12-30 | Fidia Farmaceutici | Derivati di gangliosidi |
-
1988
- 1988-07-19 IT IT8848208A patent/IT1224513B/it active
-
1989
- 1989-07-14 ZA ZA895367A patent/ZA895367B/xx unknown
- 1989-07-17 PH PH38954A patent/PH26117A/en unknown
- 1989-07-18 AU AU38190/89A patent/AU624164B2/en not_active Ceased
- 1989-07-18 DK DK354589A patent/DK354589A/da not_active Application Discontinuation
- 1989-07-18 DE DE68911049T patent/DE68911049T2/de not_active Expired - Fee Related
- 1989-07-18 EP EP89113160A patent/EP0351784B1/en not_active Expired - Lifetime
- 1989-07-18 AT AT89113160T patent/ATE97812T1/de not_active IP Right Cessation
- 1989-07-18 ES ES89113160T patent/ES2061821T3/es not_active Expired - Lifetime
- 1989-07-19 JP JP1187237A patent/JPH0278622A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| PH26117A (en) | 1992-02-24 |
| EP0351784B1 (en) | 1993-12-01 |
| EP0351784A2 (en) | 1990-01-24 |
| DK354589D0 (da) | 1989-07-18 |
| DK354589A (da) | 1990-01-20 |
| IT8848208A0 (it) | 1988-07-19 |
| EP0351784A3 (en) | 1990-12-27 |
| DE68911049T2 (de) | 1994-06-01 |
| ATE97812T1 (de) | 1993-12-15 |
| IT1224513B (it) | 1990-10-04 |
| AU3819089A (en) | 1990-01-25 |
| DE68911049D1 (de) | 1994-01-13 |
| JPH0278622A (ja) | 1990-03-19 |
| AU624164B2 (en) | 1992-06-04 |
| ZA895367B (en) | 1990-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2177780T3 (es) | Medicamentos para el tratamiento de enfermedades autoinmunes usando interferon tau. | |
| DK1296652T3 (da) | Topiske farmaceutiske formuleringer og behandlingsfremgangsmåder | |
| ATE323473T1 (de) | Pharmazeutische zusammensetzungen enthaltend resveratrol und verwendungen davon | |
| NO20001567D0 (no) | Bioadhesive sammensetninger og fremgangsmåter for topisk administrering av aktive midler | |
| ES2184145T3 (es) | Compuestos de acido sulfonico o sulfonilamino-n-(heteroaralquil)-azaheterociclilamida. | |
| DE59911740D1 (de) | Topisch anwendbare mittel gegen nagelpilzerkrankungen | |
| ES2177084T3 (es) | Uso de derivados de benzohidrilo sulfinilo para tratar la somnolencia de origen medicamentoso. | |
| BR0014912A (pt) | Tratamento de distúrbios do sono usando desloratadina | |
| SE9701161D0 (sv) | New use I | |
| NO994165L (no) | Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet | |
| ES2119165T3 (es) | Nueva actividad de cofactor anticoagulante. | |
| DE60115432D1 (de) | Apoptotische körper zur verwendung in der behandlung von t-zell-vermittelten- und entzündungserkrankungen | |
| ES2143467T3 (es) | Agente terapeutico para el tratamiento de las heridas. | |
| ES2142388T3 (es) | Agente anti-diabetico. | |
| DE60031016D1 (de) | Verwendung von Antiseptika zur Herstellung von Arzneimitteln zur Prophylaxe und Behandlung von Entzündungen im Korperinneren des Menschen | |
| ES2061821T3 (es) | Utilizacion terapeutica del derivado ester isopropilo de monosialgangliosido en patologias nerviosas con componente inflamatoria. | |
| ES2055163T3 (es) | Utilizacion del cofactor-enzima nadph para la preparacion de un medicamento asi como el medicamento preparado de este modo y procedimiento para su preparacion. | |
| AR015956A1 (es) | Composiciones de citoquinas oromucosales y usos de las mismas | |
| AR010432A1 (es) | Composiciones farmaceuticas que contienen acido ricinoleico y su uso para la terapia antiinflamatoria y analgesica | |
| AR023452A1 (es) | Utilizacion del osanetant para preparacion de medicamentos utiles en el tratamiento de los trastornos del humor | |
| ES2144857T3 (es) | Utilizacion de derivados benzonaftalenicos para la fabricacion de medicamentos destinados para el tratamiento de las enfermedades del sistema nervioso. | |
| HUP0204180A2 (hu) | Külsőleges készítmény és alkalmazása allergiás dermatitisz kezelésére | |
| ES2086518T3 (es) | Compuesto farmaceutico con accion cicatrizante. | |
| AR007738A1 (es) | El uso de un sensibilizador a la leptina o un derivado farmaceuticamente aceptable del mismo para la manufactura de un medicamento util para eltratamiento y/o profilaxis de la resistencia a la leptina y/o estados asociados con la resistencia a la leptina y/o sus complicaciones | |
| ES2165788B1 (es) | Empleo de la levadura de cerveza en la elaboracion de un medicamento para el tratamiento del sindrome x fragil. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 351784 Country of ref document: ES |